Cargando…
Molecular testing to deliver personalized chemotherapy recommendations: risking over and undertreatment
BACKGROUND: In the adjuvant setting of cancer treatment, de-escalation strategies have the goal of omitting or minimizing treatment in patients, without compromising outcomes. Historically, eligibility for adjuvant treatment solely relied on the patient’s clinical and tumor’s pathological characteri...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644653/ https://www.ncbi.nlm.nih.gov/pubmed/36348413 http://dx.doi.org/10.1186/s12916-022-02589-6 |